Since WY-14643 (Pirinixic acid) is a well established and highly selective PPARα agonist, treatment with WY-14643 could prevent hepatic steatosis during ethanol ingestion (Fischer et al. 2003; Chen et al. 2021). The gene discussed is PPARA; the disease is fatty liver disease.